Scientists are talking about a new drug to treat Alzheimer's disease after noticing positive results in the first trial.

They are claiming that the drug has shown positive results by halting the mental decline in the Alzheimer's condition for three long years.

If scientists are to be believed then chances are higher that the medical industry will get this new treatment within a decade.

In the trial, researchers gave the injections of the drug immunoglobulin to the patients after every two weeks. They said that the drug that has been made from antibodies in human blood has shown fantastic results by stopping the decline in patient's cognition power, memory status, daily functioning routine or mood swinging.

The drug Immunoglobulin is presently given to patients suffering from immune deficiency. Researchers believe that the drug has properties to protect the brains of humans too and thus can prove a successful treatment for those, who are at early stage of Alzheimer's.

Each dose of the drug works fantastically as it is extracted from the plasma of 1,000 blood donors.

Regarding this new discovery, Professor Clive Ballard, director of research at the Alzheimer's Society, said: "This is probably the most exciting drug we know about that is currently in the late stages of research."